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ABSTRACT 
To determine the prevalence and significance of Helicobacter pylori (H. pylori) infection, biop-
sies of the antral mucosa were obtained from 139 patients and 43 asymptomatic volunteers. The 
specimens were examined by hematoxylin-eosin staining and the urease test. The detection rate 
of H. pylori by histologic examination was 91.3% in patients with duodenal ulcer, 75.0% in those 
with combined duodenal and gastric ulcer, 63.6% in those with gastric ulcer, 22.9% in those 
with gastric carcinoma, 36.4% in those with gastric adenoma, 14.3% in those with gastric hyper-
plastic polyp, and 51.7% in those with gastritis, and the respective percentages detected by the 
urease test were 91.3%, 75.0%, 54.5%, 28.6%, 27.3%, 14.3%, and 44.8%. H. pylori was also 
detected in 10/43 (23.3%) asymptomatic healthy volunteers by histology and the urease test. The 
prevalence of H. pylori was significantly higher in the patients than in the asymptomatic healthy 
volunteers (p < 0.05). H. pylori was detected in 62.9% of patients with endoscopic erosive gastri-
tis and in 97. 9% of those with histologically proven chronic active gastritis. The urease test was 
positive in 77/82 patients who were histologically positive for the organism (sensitivity: 93.9%), 
and it was negative in 98/100 patients who were negative by histology (specificity: 98.0%). Thus, 
there was over 90% agreement between the urease test and histology. Our investigations showed 
that H. pylori was closely related to peptic ulcers and antral gastritis, and that the urease test 
provides a simple, rapid and accurate diagnosis of H. pylori infection. 
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Since Campylobacter pylori (now called Helicobac-
ter pylori) was first isolated in 198335), this organ-
ism has been increasingly recognized as an 
important factor in the development of chronic gas-
tritis and peptic ulcer disease. In addition, recent 
reports have indicated a close relationship between 
Helicobacter pylori (H. pylori) and gastric 
carcinoma4•28). The organisms have been observed 
in 55-86% of patients with gastritis1•6•11•16•23•33\ 
57-96% of patients with gastric ulcer, and 70-100% 
of patients with duodenal ulcer2•11•12•16•18•26•29·31•33). 
Eradication of H. pylori results in a lower relapse 
rate of duodenal ulcer8•19) as well as in the im-
provement of gastritis5•10•27•31). The fulfillment of 
Koch's postulates in human volunteer studies and 
investigations involving antimicrobial therapy17•22) 
have shown that eradication of H. pylori coincides 
with the remission of gastritis, supporting the 
hypothesis that the organism is indeed the major 
cause of this condition. 
Several diagnostic tests have been used to evalu-
ate the presence of H. pylori in the gastric muco-
sa. Special culture techniques have been devised to 
grow this fastidious organism18•30•34). Histologic ex-
amination of gastric biopsy is performed after stain-
ing with hematoxylin-eosin34), Giemsa stain15\ the 
Warthin-Starry technique25) or acridine-orange14). 
More recently, an immunocytochemical technique 
utilizing an unlabeled anti-H. pylori antibody 
peroxidase-antiperoxidase method has been 
developed24). Rapid methods of identification utiliz-
ing the organism's urease activity have also been 
successful9•32), including a 14C-urea breath test20•21). 
H. pylori splits 14C-urea into ammonia and 14C02• 
The 14C02 is absorbed and exhaled and can be 
measured. Serum IgM and IgG antibodies to H. 
pylori can be measured by complement fixation or 
by means of an enzyme-linked immunosorbent 
assay3•7•21). Each of these methods has its own ad-
vantages and disadvantages,· with some being more 
widely available than others. In the present study, 
we confirmed that H. pylori infection is correlated 
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with gastritis and peptic ulcer disease, and also 
evaluated the usefulness of the rapid urease test 
for identifying this organism. 
MATERIALS and METHODS 
Patient population and study design: One hun-
dred and thirty-nine patients who presented to the 
Gastroenterology Endoscopic Unit at Hiroshima 
University Medical Hospital between April 1990 
and June 1991 for the endoscopic evaluation of up-
per GI symptoms or mass screening for gastric car-
cinoma were examined to detect the presence of H. 
pylori. The patient group consisted of 94 males and 
45 females and their mean age ( ± SD) was 58.0 
± 16.2 years. At endoscopy, three biopsies were 
taken routinely from the midportion of the en-
doscopically normal antral mucosa, along the less-
er curvature. One of these specimens was used for 
the rapid urease test (Delta West Ltd, Canning 
Vale, Australia), and the others were processed for 
histologic examination. New disinfected biopsy for-
ceps were used to obtain each biopsy. A biopsy 
specimen of any lesion noted at endoscopy was also 
obtained for histologic evaluation. 
In addition, antral mucosa biopsies obtained from 
43 asymptomatic volunteers ( 40 males and 3 fe-
males with a mean age of 23.8 ± 5.5 years) were 
also subjected to the urease test and examined 
histologically. These subjects were either medical 
students or soldiers. Informed consent to the study 
was obtained from all patients and volunteers. 
U rease test: All tests were evaluated by the 
same operator (S.O.). A test tablet containing 
43.974 mg urea and 0.0075 mg phenol red was dis-
solved with 0.5 ml distilled water in one reaction 
vessel. A biopsy of the antrum was placed in this 
solution. A test was considered positive when the 
indicator turned from amber to dark pink, and most 
positive tests became so within 180 min. The test 
was considered as negative if there was no color 
change, or only a partial color change to orange, 
at the end of 24 h. 
Histological examination: Two or more specime-
ns obtained from the gastric antral mucosa were 
placed in 10% formalin and subsequently stained 
with hematoxylin and eosin. All specimens were 
then evaluated by one investigator (K.H.) under a 
x 100 oil immersion lens. This investigator had no 
knowledge of patient identity and of the results of 
the urease test. If the characteristic spiral H. pylori 
organisms were seen, the result was considered 
positive. If H. pylori was not evident in the speci-
mens, the original tissue blocks were recut, stained 
with Giemsa stain, and re-examined. In addition, 
two specimens from the endoscopically normal an-
tral mucosa were classified for gastritis as follows: 
normal, no inflammatory cells or a normal number 
of such cells; chronic inactive gastritis, an increased 
number of lymphocytes and plasma cells in the la-
mina propria; chronic active gastritis, neutrophil in-
filtration in addition to the changes of chronic gas-
tritis; and atrophic gastritis, complete or near com-
plete loss of pyloric glands, and/or presence of 
intestinal metaplasia. Chronic inactive gastritis was 
subclassified as mild or severe and the presence of 
intestinal metaplasia was noted. The number of bac-
teria present was graded as follows: Nil = no bac-
teria seen. Mild = occasional bacteria present, but 
not seen in every high power field. Moderate = 
bacterial numbers intermediate between mild and 
severe. Severe = numerous bacteria in all fields, 
usually confluent and covering the entire mucosal 
surface. 
Endoscopic features of antral gastritis: The en-
doscopic features of antral gastritis were catego-
rized as follows: (1) normal; (2) erosive gastritis, 
defined as the presence of gastric erosions; (3) 
superficial gastritis, defined as the presence of 
erythema without gastric erosions; and (4) atroph-
ic gastritis, defined as an easily visible venous 
plexus or the presence of intestinal metaplasia. 
Statistical analysis: The Fisher exact test or the 
chi-squared test was used to determine the sig-
nificance of differences between the groups. 
RESULTS 
Patients were considered positive for H. pylori if 
the bacteria were detected by hematoxylin-eosin 
and/or Giemsa staining (Fig. 1). The associations be-
tween the various endoscopic diagnoses and the 
presence of H. pylori are summarized in Table 1. 
The organism was found by histologic examination 
in 21/23 (91.3%) patients with duodenal ulcer, 9/12 
(75.0%) patients with combined duodenal and gas-
tric ulcers, 14/22 (63.6%) patients with gastric ul-
cer, 8/35 (22.9%) patients with gastric carcinoma, 
4/11 (36.3%) patients with gastric adenoma, 117 
(14.3%) patients with gastric polyp, and 15/29 
(51.7%) patients with gastritis. The percentages of 
these groups who were positive to the urease test 
were 91.3%, 75.0%, 54.5%, 28.6%, 27.3%, 14.3%, 
and 44.8% respectively. H. pylori was detected by 
histology and the urease test in 10/43 (23.3%) 
healthy volunteers. When endoscopic examination 
was performed for this protocol, one healthy volun-
teer (a 23-year-old male) had an unsuspected active 
duodenal ulcer, 10/43 volunteers had mild erosive 
gastritis, and the rest were normal. 
The relationship between an endoscopic diagno-
sis of antral gastritis and the presence of H. pylori 
is shown in Table 2. Of the total of 182 subjects 
undergoing endoscopy (139 patients and 43 volun-
teers), 32 were diagnosed as having normal muco-
sa, 10 as having superficial gastritis, 70 as having 
erosive gastritis, and 70 as having atrophic gastri-
tis. H. pylori was detected by histology in 13/32 
(40.6%) patients with an endoscopically normal an-
tral mucosa, in 44/70 (62.9%) patients with erosive 
gastritis, and in 25/70 (35.7%) patients with atroph-
ic gastritis. On the other hand, H. pylori could not 
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Fig. 1 a. The characteristic appearance of H. pylori 
infection in gastric biopsy taken from the antrum. This 
is a severe active gastritis with widespread neutrophil-
ic inflammation and marked choronic inflammation. 
Neutrophils are present within the gastric epithelium. 
Epithelial degeneration and mucin depletion are also 
seen. (Hematoxylin and eosin, original magnification 
x 66) 
Fig. 1 b. H. pylori as visualized with the Giemsa stain. 
The bacteria appear as dark spirals lining the epithelial 
cells and within the mucus layer. (Original magnifica-
tion x 330) 
be detected in 10 patients with superficial gastri-
tis. The detection rates of the organism by the 
urease test were 40.6% (normal), 61.4% (erosive), 
and 32.9% (atrophic). The relationship between the 
histological diagnosis of the antral mucosa and H. 
pylori is shown in Table 3. In all 20 patients with 
histologically proven normal mucosa, H. pylori could 
not be detected by histologic examination or the 
urease test. H. pylori was detected by histology in 
10/51 (19.6%) patients with mild inactive gastritis, 
in 13/25 (52.0%) patients with moderate inactive 
gastritis, in 9/16 (56.3%) patients with severe in-
active gastritis, in 47/48 (97.9%) patients with ac-
tive gastritis, and in 3/22 (13.6%) patients with 
atrophic gastritis. 
A urease test was performed in all 139 patients 
and all 43 healthy volunteers, and the results were 
compared with those of histologic examination 
(Table 4). There was a very close relationship be-
tween the detection of H. pylori by histology and 
by a positive rapid urease test. The urease test de-
tected H. pylori in 77 /82 patients with histologic 
evidence of the organism (sensitivity: 93.9%), and 
the test was negative in 98/100 patients who were 
negative by histologic examination (specificity: 
98.0%). The relationship between the histologic 
grade of H. pylori infection and the urease reac-
tion time is shown in Table 5. Of the 82 specimens 
in which H. pylori was detected, 77 had a cor-
responding positive urease test. The greater the 
number of H. pylori seen in the biopsy specimen, 
the more rapidly the end-point color developed in 
the test wells. Among 82 specimens where H. 
pylori was detected by histology, 63 (76.8%) were 
positive by the urease test within 180 min. 
DISCUSSION 
The present study confirms previous reports that 
the high prevalence of H. pylori infection is close-
ly related to chronic gastritis and peptic ulcer dis-
ease. In addition, we showed that the urease test 
provides a rapid and accurate method for the di-
agnosis of H. pylori infection. The prevalence of H. 
pylori in gastric ulcer patients is reported as 70% 
or more and it is 80-100% in those with duodenal 
ulcer2•11,12•16•18•26•29-31•33). Our study found a prevalence 
of H. pylori in gastric ulcer patients that was simi-
lar to the reported level. Duodenal ulcer patients 
also had a similar prevalence of H. pylori, but the 
prevalence rate of 22.9% in gastric carcinoma was 
lower than that reported by Parsonnet28). 
The asymptomatic young volunteers had a low in-
cidence (23.3%) of H. pylori infection of the antral 
mucosa, which was similar to the 13%-32% inci-
dence of H. pylori in healthy volunteers reported 
by others6•29•31). It is of interest that one of the H. 
pylori-positive asymptomatic volunteers had an un-
suspected active duodenal ulcer. 
Our investigation also confirmed that the preva-
lence of H. pylori infection was closely related to 
a diagnosis of antral gastritis by endoscopy or 
histology. The infection rate in patients with en-
doscopic erosive gastritis was 62.9%, and this was 
significantly higher than that in patients with en-
doscopically normal antral mucosa (40.6%), super-
ficial gastritis (0%) or atrophic gastritis (35.7%). 
The organism was identified histologically in 97. 9% 
of the patients with chronic active gastritis and in 
34.8% of those with inactive gastritis. On the other 
hand, H. pylori could not be detected in 20 patients 
with a histologically normal antrum, and the inci-
dence was a low 13.6% in patients with atrophic 
gastritis. The reasons why H. pylori was detected 
in some patients with normal endoscopic findings 
and was not detected in those with severe gastri-
tis remain largely obscure. 
The sensitivity and specificity of the urease test 
was very good, and this indicates that it provides 
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Table 1. Endoscopic diagnosis and the presence of H. pylori** 
Detection of H. pylori 
Endoscopic No. of 
diagnosis patients 
Duodenal ulcer 23 
Combined duodenal 12 
and gastric ulcer 
Gastric ulcer 22 
Gastric carcinoma 35 
Gastric adenoma 11 
Gastric polyp 7 
Gastritis 29 
Mean 
age (yr) 
42.4 
57.3 
60.0 
68.2 
68.7 
61.7 
51.8 
Histology 
n (%) 
21 (91.3)* 
9 (75.0)* 
14 (63.6)* 
8 (22.9) 
4 (36.4) 
1 (14.3) 
15 (51.7)* 
Urease test 
n (%) 
21 (91.3)* 
9 (75.0)* 
12 (54.5)* 
10 (28.6) 
3 (27.3) 
1 (14.3) 
13 (44.8)* 
Healthy volunteers 43 23.8 10 (23.3) 10 (23.3) 
* p < 0.05 : compared with the asymptomatic healthy volunteers. 
* * The presence of H. pylori was detected in the endoscopically normal antral mucosa. 
Table 2. Endoscopic findings in relation to detection of H. pylori** 
Endoscopic appearance No. of 
of antral mucosa patients 
Normal mucosa 32 
Superficial gastritis 10 
Erosive gastritis 70 
Atrophic gastritis 70 
* p<0.05 compared with nomal mucosa. 
Histology 
n (%) 
13 (40.6) 
0 ( 0 )* 
44 (62.9)* 
25 (35.7) 
Detection of H. pylori 
Urease test 
n (%) 
13 (40.6) 
0 ( 0 )* 
43 (61.4)* 
23 (32.9) 
* * The presence of H. pylori was detected in the endoscopically normal antral mucosa. 
Table 3. Histology of the endoscopically normal antral mucosa in relation to the presence of H. pylori 
Detection of H. pylori 
Mucosal histology No. of Histology Urease test patients n (%) n (%) 
Normal mucosa 20 0 ( 0 ) 0 ( 0 ) 
Chronic inactive gastritis 
mild 51 10 (19.6)* 8 (15.7)* 
moderate 25 13 (52.0)* 13 (52.0)* 
severe 16 9 (56.3)* 11 (68.8)* 
Active chronic gastritis 48 47 (97.9)* 44 (91.7)* 
Atrophic gastritis 22 3 (13.6)* 3 (13.6)* 
* p<0.05: compared with normal mucosa. 
Table 4. Comparison of detection of H. pylori by histologic examination and the urease test 
Histologic 
examination 
Negative 
Positive 
No. of 
patients 
100 
82 
Negative 
n (%) 
98 (98.0) 
5 ( 6.1) 
Urease test 
Positive 
n (%) 
2 ( 2.0) 
77 (93.9) 
Table 5. Comparison of histologic grade of H. pylori infection and the urease test reaction time 
Urease reaction time (min) 
H. pylori infection No. of 
grade specimens 0-30 >30-180 >180 Negative 
Nil 100 0 0 2 98 
Mild 42 10 14 13 5 
Moderate 22 10 11 1 0 
Severe 18 15 3 0 0 
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a useful method for the diagnosis of H. pylori in-
fection. Culture of this organism is quite difficult 
and requires a motivated microbiologist to achieve 
success. Special handling of specimens is also re-
quired (prompt incubation and processing), it takes 
2-5 days to obtain a result, and the sensitivity is 
low. A major advantage of detecting H. pylori by 
histological examination using hematoxylin-eosin 
staining34> or Giemsa staining15> is that an opportu-
nity is provided to evaluate the biopsied mucosal 
tissue for microscopic gastritis. This is especially 
important in view of studies that suggest that the 
presence of H. pylori is closely related to the patho-
genesis of peptic ulcer disease or antral gastritis. 
However, one disadvantage is that reliable interpre-
tation of the stained specimens requires some prac-
tice. The rapid urease test, on the other hand, 
requires no special skill to interpret and can usually 
be completed within 180 min so that a diagnosis 
can be made before the patient leaves hospital. 
Schnell et al. reported that the greater is the num-
ber of organisms in the biopsy specimen, the more 
rapidly the indicator turns positive32>. 
The role of H. pylori in gastric carcinogenesis has 
become a topic of current interest, since H. pylori 
infection is associated with chronic gastritis and 
chronic atrophic gastritis is associated with gastric 
carcinoma. Recent studies have indicated a close 
relationship between H. pylori infection and gastric 
carcinoma4128> or atrophic gastritis of the fundus13>. 
However, we found histologic evidence of H. pylori 
in the antrum of only 22. 9% of our patients with 
gastric carcinoma in contrast to other reports of 
a high incidence of this organism in gastric carci-
noma patients. Parsonnet et al. detected H. pylori 
histologically in 33/37 (89.2%) intestinal-type gas-
tric carcinoma patients, and in 7/22 (31.8%) with 
diffuse-type gastric carcinoma28>. A more recent 
report has demonstrated that patients with atrophic 
gastritis of the fundus have a high prevalence of 
H. pylori seropositivity and a lower prevalence of 
H. pylori in histological specimens13>. It is well 
known that intestinal-type gastric carcinoma de-
velops in association with atrophic gastritis. There-
fore, H. pylori infection might be related to the 
pathogenesis of intestinal-type gastric carcinoma, 
because this organism may induce atrophic gastri-
tis affecting the gastric body. 
In conclusion, our results indicate that H. pylori 
infection might play a role in the development of 
peptic ulcer disease and antral gastritis. The urease 
test provides an easy, accurate and inexpensive 
method for the identification of this organism on 
a routine basis. However, a link between H. pylori 
and gastric carcinoma or atrophic gastritis could 
not be confirmed in this study, and further inves-
tigations, including serological or prospective 
studies, are needed to clarify this issue. 
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